| FMXKX | VSTSX | FMXKX / VSTSX | |
| Total Expense Ratio | 1.12 | 0.01 | 11,200% |
| Annual Report Gross Expense Ratio | 1.28 | 0.01 | 12,800% |
| Fund Existence | 23 years | 10 years | - |
| Gain YTD | 11.046 | 11.351 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 5000000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 282M | 2.34T | 0% |
| Annual Yield % from dividends | 0.19 | 1.05 | 18% |
| Returns for 1 year | 7.53 | 14.99 | 50% |
| Returns for 3 years | 16.45 | 68.89 | 24% |
| Returns for 5 years | -12.51 | 63.04 | -20% |
| Returns for 10 years | -36.27 | 245.06 | -15% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLRE | 43.42 | 0.37 | +0.86% |
| State Street Real Estate Sel SectSPDRETF | |||
| OSCV | 41.21 | 0.18 | +0.44% |
| Opus Small Cap Value Plus ETF | |||
| MSMR | 34.09 | 0.15 | +0.44% |
| McElhenny Sheffield Managed Risk ETF | |||
| CBOO | 24.65 | N/A | N/A |
| Calamos Bitcoin Str Alt Prt ETF-Oct | |||
| BBC | 49.38 | -0.53 | -1.05% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||